'Statistical issues' presentation slideshows

Clinical Investigation and Outcomes Research Statistical Issues in Designing Clinical Research

Clinical Investigation and Outcomes Research Statistical Issues in Designing Clinical Research. Marcia A. Testa, MPH, PhD Department of Biostatistics Harvard School of Public Health. Objective of Presentation.

654 views • 42 slides

Statistical Issues With Linear Extrapolation of Stability Data

442 views • 31 slides

FMS and the development of biostatistics during 25 years

315 views • 31 slides

A Brief Introduction to Epidemiology - XIII (Critiquing the Research: Statistical Considerations)

A Brief Introduction to Epidemiology - XIII (Critiquing the Research: Statistical Considerations). Betty C. Jung, RN, MPH, CHES. Learning/Performance Objectives. Quick review Basics of inferential statistics Common measures of association To be able to statistically critique studies

273 views • 27 slides

Online Aggregation

439 views • 26 slides

Mark A. Del Vecchio Director, Regulatory and Clinical Affairs Digene Corporation

How to Work with FDA: Industry Perspective IVD Roundtable/OIVD Workshop. Mark A. Del Vecchio Director, Regulatory and Clinical Affairs Digene Corporation. April 22, 2003. Discussion Topics. Interaction with FDA General Considerations Before you Submit During the Review

343 views • 25 slides

Statistical issues in Particle Physics analyses

368 views • 23 slides

Improving FDA/Industry Interactions: Suggestions from FDA/CDER Statisticians

Improving FDA/Industry Interactions: Suggestions from FDA/CDER Statisticians. Rafia Bhore, Ph.D. Janice Derr, Ph.D. FDA / CDER / Office of Biostatistics. The views expressed in this presentation are those of the speakers and not necessarily of the U.S. Food and Drug Administration (FDA).

375 views • 22 slides

Improving FDA/Industry Interactions: Suggestions from FDA/CDER Statisticians

Improving FDA/Industry Interactions: Suggestions from FDA/CDER Statisticians. Rafia Bhore, Ph.D. Janice Derr, Ph.D. FDA / CDER / Office of Biostatistics. The views expressed in this presentation are those of the speakers and not necessarily of the U.S. Food and Drug Administration (FDA).

316 views • 22 slides

Mainstreaming Statistics in Africa: A Summary of IMF Activities

345 views • 19 slides

Feeding Technique Potential risk Factor for Childhood Obesity

Feeding Technique Potential risk Factor for Childhood Obesity. Louise Giovannone , Patty Flanagan, Elizabeth Haver -Browne. SIGNIFICANCE OF THE PROBLEM. Childhood obesity presents a significant public health problem

281 views • 15 slides

Harmonising international trade data for inter-country input-output analysis: statistical issues

Harmonising international trade data for inter-country input-output analysis: statistical issues . Dong GUO, Norihiko YAMANO and Colin WEBB September 22 nd , 2008 WPGTS, Paris. Background. Economic globalization: the significant trade in intermediate goods and services globally

228 views • 13 slides

134 views • 13 slides

Statistics for Molecular Biology and Bioinformatics

Statistics for Molecular Biology and Bioinformatics. Instructor: Ron S. Kenett Email: ron@kpa.co.il Course Website: www.kpa.co.il/biostat Course textbook: MODERN INDUSTRIAL STATISTICS, Kenett and Zacks, Duxbury Press, 1998. Course Syllabus. Understanding Variability

133 views • 12 slides

IASE Satellite Conference on Statistics Literacy

124 views • 11 slides

Statistical Cooperation with ENP-East

Statistical Cooperation with ENP-East. Twelfth meeting of the Management Group on Statistical Cooperation 18-19 March 2010 Luxembourg Agenda item 6.2. Background. ENP East countries - Armenia, Azerbaijan, Belarus, Georgia, Moldova and Ukraine

382 views • 8 slides

Statistical Issues for GLAST

183 views • 7 slides

Exposure of zebrafish embryos to solvents. The statistical issues

200 views • 7 slides